1-[(4-Chlorophenyl)methoxy]-2-(4-methoxyphenyl)-1H-1,3-benzodiazole

Catalog No. :
ACYZTF327
CAS No. :
339009-75-5
Molecular Formula :
C21H17ClN2O2
Molecular Weight :
364.83

IUPAC Name:1-((4-chlorobenzyl)oxy)-2-(4-methoxyphenyl)-1H-benzo[d]imidazole

1-[(4-Chlorophenyl)methoxy]-2-(4-methoxyphenyl)-1H-1,3-benzodiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(4-Chlorophenyl)methoxy]-2-(4-methoxyphenyl)-1H-1,3-benzodiazole
IUPAC Name1-((4-chlorobenzyl)oxy)-2-(4-methoxyphenyl)-1H-benzo[d]imidazole
MDL No.MFCD00141238
Molecular FormulaC21H17ClN2O2
Molecular Weight364.83
SMILESCOC1=CC=C(C2=NC3=CC=CC=C3N2OCC4=CC=C(Cl)C=C4)C=C1
InChI KeyZCFDELSFKXFTBV-UHFFFAOYSA-N
Synonym4-(1-[(4-CHLOROBENZYL)OXY]-1H-1,3-BENZIMIDAZOL-2-YL)PHENYL METHYL ETHER;1-[(4-CHLOROBENZYL)OXY]-2-(4-METHOXYPHENYL)-1H-1,3-BENZIMIDAZOLE;1-[(4-chlorophenyl)methoxy]-2-(4-methoxyphenyl)-1H-1,3-benzodiazole;1H-Benzimidazole, 1-[(4-chlorophenyl)methoxy]-2-(4-methoxyphenyl)-
CAS No.339009-75-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYZTF327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYZTF327 route product structure diagram
    ACYZTF327339009-75-5
Inquiry

2. ACYZTF327 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYZTF327 route product structure diagram
    ACYZTF327339009-75-5
Inquiry

Comments (0)